Should we now ADOPT glitazones earlier in treatment of type 2 diabetes?
Howat
Isabel
I
Cleland
Stephen J
SJ
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007328:Insulin / Q000378:metabolism; D045162:Thiazolidinediones / Q000008:administration & dosage* / Q000009:adverse effects
D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones